Showing 1 - 16 results of 16 for search 'Renata Bartesaghi', query time: 0.06s Refine Results
  1. 1
    The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives

    The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives by Fiorenza Stagni, Renata Bartesaghi

    Published 2022-05-01
    Get full text
    Article
  2. 2
    The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome

    The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome by Fiorenza Stagni, Beatrice Uguagliati, Marco Emili, Andrea Giacomini, Renata Bartesaghi, Sandra Guidi

    Published 2021-03-01
    Get full text
    Article
  3. 3
    Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone

    Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone by Daniela Valenti, Fiorenza Stagni, Marco Emili, Sandra Guidi, Renata Bartesaghi, Rosa Anna Vacca

    Published 2021-12-01
    Get full text
    Article
  4. 4
    APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome

    APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome by Stefania Trazzi, Claudia Fuchs, Marianna De Franceschi, Valentina Maria Mitrugno, Renata Bartesaghi, Elisabetta Ciani

    Published 2014-07-01
    Get full text
    Article
  5. 5
    Corrigendum to “APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome” [Neurobiology of Disease 67 (2014) 24–36]

    Corrigendum to “APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome” [Neurobiology of Disease 67 (2014) 24–36] by Stefania Trazzi, Claudia Fuchs, Marianna De Franceschi, Valentina Maria Mitrugno, Renata Bartesaghi, Elisabetta Ciani

    Published 2020-05-01
    Get full text
    Article
  6. 6
    Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome.

    Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome. by Fiorenza Stagni, Jacopo Magistretti, Sandra Guidi, Elisabetta Ciani, Chiara Mangano, Laura Calzà, Renata Bartesaghi

    Published 2013-01-01
    Get full text
    Article
  7. 7
    Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse

    Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse by Andrea Giacomini, Fiorenza Stagni, Marco Emili, Beatrice Uguagliati, Roberto Rimondini, Renata Bartesaghi, Sandra Guidi

    Published 2019-06-01
    Get full text
    Article
  8. 8
    Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder

    Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder by Claudia Fuchs, Roberto Rimondini, Rocchina Viggiano, Stefania Trazzi, Marianna De Franceschi, Renata Bartesaghi, Elisabetta Ciani

    Published 2015-10-01
    Get full text
    Article
  9. 9
    Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome

    Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome by Andrea Giacomini, Fiorenza Stagni, Stefania Trazzi, Sandra Guidi, Marco Emili, Elizabeth Brigham, Elisabetta Ciani, Renata Bartesaghi

    Published 2015-10-01
    Get full text
    Article
  10. 10
    Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice

    Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice by Fiorenza Stagni, Andrea Giacomini, Sandra Guidi, Elisabetta Ciani, Elena Ragazzi, Mirco Filonzi, Rosaria De Iasio, Roberto Rimondini, Renata Bartesaghi

    Published 2015-02-01
    Get full text
    Article
  11. 11
    Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome

    Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome by Fiorenza Stagni, Maria Elisa Salvalai, Andrea Giacomini, Marco Emili, Beatrice Uguagliati, Er Xia, Mariagrazia Grilli, Renata Bartesaghi, Sandra Guidi

    Published 2019-09-01
    Get full text
    Article
  12. 12
    Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome

    Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome by Francesco Ravaioli, Fiorenza Stagni, Sandra Guidi, Chiara Pirazzini, Paolo Garagnani, Paolo Garagnani, Alessandro Silvani, Giovanna Zoccoli, Renata Bartesaghi, Maria Giulia Bacalini

    Published 2024-05-01
    Get full text
    Article
  13. 13
    Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling

    Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling by Claudia Fuchs, Stefania Trazzi, Roberta Torricella, Rocchina Viggiano, Marianna De Franceschi, Elena Amendola, Cornelius Gross, Laura Calzà, Renata Bartesaghi, Elisabetta Ciani

    Published 2014-10-01
    Get full text
    Article
  14. 14
    Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome

    Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome by Marco Emili, Fiorenza Stagni, Maria Elisa Salvalai, Beatrice Uguagliati, Andrea Giacomini, Christelle Albac, Marie-Claude Potier, Mariagrazia Grilli, Renata Bartesaghi, Sandra Guidi

    Published 2020-07-01
    Get full text
    Article
  15. 15
    Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome

    Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome by Fiorenza Stagni, Alessandra Raspanti, Andrea Giacomini, Sandra Guidi, Marco Emili, Elisabetta Ciani, Alessandro Giuliani, Andrea Bighinati, Laura Calzà, Jacopo Magistretti, Renata Bartesaghi

    Published 2017-07-01
    Get full text
    Article
  16. 16
    Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome

    Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome by Maria Lavinia Bartolucci, Chiara Berteotti, Sara Alvente, Stefano Bastianini, Sandra Guidi, Viviana Lo Martire, Gabriele Matteoli, Alessandro Silvani, Fiorenza Stagni, Marcello Bosi, Giulio Alessandri-Bonetti, Renata Bartesaghi, Giovanna Zoccoli

    Published 2021-11-01
    Get full text
    Article

Search Tools: